Lyons, France

Annie B Matibet


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Annie B Matibet: Innovator in Pharmaceutical Chemistry

Introduction

Annie B Matibet is a notable inventor based in Lyons, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with inflammation-reducing properties. Her work has implications for pain management and fever reduction, showcasing her commitment to advancing medical science.

Latest Patents

Annie B Matibet holds a patent for "5-Substituted indan-2-carboxylic acid and functional derivatives." This invention includes compounds that possess inflammation-reducing properties, characterized by a general formula where R represents various functional groups, including phenyl and lower alkyls, among others. The compounds are noted for their low toxicity, analgesic activity, and antipyretic effects, making them valuable in therapeutic applications.

Career Highlights

Annie B Matibet is associated with Lipha, Lyonnaise Industrielle Pharmaceutique, where she has been instrumental in research and development. Her innovative work has led to advancements in pharmaceutical formulations, contributing to the company's reputation in the industry.

Collaborations

Annie has collaborated with esteemed colleagues, including Michel Bayssat and Francis Sautel. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Annie B Matibet's contributions to pharmaceutical chemistry exemplify her dedication to innovation and improving healthcare outcomes. Her patented work continues to influence the field, highlighting the importance of research in developing effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…